Cody J Peer (Cody Peer)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 25

Top Topics

Brain Metastases

Renal Cell Carcinoma

Positive Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical pharmacology

Science translational medicine

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Michiyo Iba, Changyoun Kim, Somin Kwon, Marcell P Szabo, Liam Horan-Portelance, Cody J Peer, William Douglas Figg, Xylena Reed, Jinhui Ding, Seung-Jae Lee, Robert A Rissman, Mark R Cookson, Cassia Overk, Wolf Wrasidlo, Eliezer Masliah
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. Science translational medicine 15 (695) (2023)
Sarah Jenkins, Wei Zhang, Seth M Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S Armstrong, Eric Burton, DeeDee K Smart, Ritu Shah, Cody J Peer, Brett Mozarsky, Oluwatobi Arisa, William Douglas Figg, Tito R Mendoza, Elizabeth Vera, Priscilla Kaliopi Brastianos, Scott L Carter, Mark R Gilbert, Carey K Anders, Caitriona Cahir, Carol Tweed, Karen Lisa Smith, Imran Khan, Stanley Lipkowitz, Patricia S Steeg, Alexandra S Zimmer
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Melissa L Abel, Nobuyuki Takahashi, Cody J Peer, Christophe E Redon, Samantha Nichols, Rasa Vilimas, Min-Jung Lee, Min-Jung Lee, Meenakshi Shelat, Robbie Kattappuram, Linda Sciuto, Danielle Pinkiert, Chante Graham, Donna Butcher, Baktiar O Karim, Ajit Kumar Sharma, Justin Malin, Rajesh Kumar, Christopher W Schultz, Shubhank Goyal, Jaydira Del Rivero, Manan Krishnamurthy, Deep Upadhyay, Brett A Schroeder, Tristan M Sissung, Manoj Tyagi, Jung Kim, Yves Pommier, Mirit I Aladjem, Mark Raffeld, William Douglas Figg, Jane Trepel, Liqiang Xi, Parth Desai, Anish Thomas
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Melissa L Abel, Nobuyuki Takahashi, Cody J Peer, Christophe E Redon, Samantha Nichols, Rasa Vilimas, Min-Jung Lee, Min-Jung Lee, Meenakshi Shelat, Robbie Kattappuram, Linda Sciuto, Danielle Pinkiert, Chante Graham, Donna Butcher, Baktiar O Karim, Ajit Kumar Sharma, Justin Malin, Rajesh Kumar, Christopher W Schultz, Shubhank Goyal, Jaydira Del Rivero, Manan Krishnamurthy, Deep Upadhyay, Brett A Schroeder, Tristan M Sissung, Manoj Tyagi, Jung Kim, Yves Pommier, Mirit I Aladjem, Mark Raffeld, William Douglas Figg, Jane Trepel, Liqiang Xi, Parth Desai, Anish Thomas
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jerry T Wu, Adam Cheuk, Kristine Isanogle, Christina Robinson, Xiaohu Zhang, Michele Ceribelli, Erin Beck, Paul Shinn, Carleen Klumpp-Thomas, Kelli M Wilson, Crystal McKnight, Zina Itkin, Hiroshi Sotome, Hiroshi Hirai, Elizabeth Calleja, Volker Wacheck, Brad Gouker, Cody J Peer, Natalia Corvalan, David Milewski, Yong Y Kim, William Douglas Figg, Elijah F Edmondson, Craig J Thomas, Simone Difilippantonio, Jun S Wei, Javed Khan
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma. Cancers 15 (16) (2023)
Cody J Peer, Keith T Schmidt, Oluwatobi Arisa, William J Richardson, Koosha Paydary, Daniel A Goldstein, James L Gulley, William D Figg, Mark J Ratain
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response Simulation. Journal of clinical pharmacology (2023)
Cody J Peer, Keith T Schmidt, Oluwatobi Arisa, William J Richardson, Koosha Paydary, Daniel A Goldstein, James L Gulley, William D Figg, Mark J Ratain
In Silico Re-Optimization of Atezolizumab Dosing using Population Pharmacokinetic and Exposure-Response Simulation. Journal of clinical pharmacology (2023)
Michiyo Iba, Changyoun Kim, Somin Kwon, Marcell P Szabo, Liam Horan-Portelance, Cody J Peer, William Douglas Figg, Xylena Reed, Jinhui Ding, Seung-Jae Lee, Robert A Rissman, Mark R Cookson, Cassia Overk, Wolf Wrasidlo, Eliezer Masliah
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. Science translational medicine 15 (695) (2023)
Katherine E Warren, Gilbert Vezina, Mark Krailo, Linda Springer, Allen Buxton, Cody J Peer, William Douglas Figg, Chris William-Hughes, Sandy Kessel, Maryam Fouladi, Amar J Gajjar, Daniel C Bowers
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kevin C Conlon, Dionysios C Watson, Thomas A Waldmann, Antonio Valentin, Cristina Bergamaschi, Barbara K Felber, Cody J Peer, William Douglas Figg, E Lake Potter, Mario Roederer, Douglas G McNeel, John A Thompson, Sumati V Gupta, Rom S Leidner, Andrea Wang-Gillam, Nehal S Parikh, Debby Long, Sema Kurtulus, Lang Ho Lee, Niladri Roy Chowdhury, Florent Bender, George N Pavlakis
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors. Journal for immunotherapy of cancer 9 (11) (2022)
John A Ligon, R Taylor Sundby, Mary Frances Wedekind Malone, Fernanda I Arnaldez, Jaydira Del Rivero, Lori S Wiener, Ramaprasad Srinivasan, Melissa Spencer, Amanda Carbonell, Haiyan Lei, Jack F Shern, Seth M Steinberg, William Douglas Figg, Cody J Peer, Sara M Zimmerman, Josquin Moraly, Xia Xu, Stephen Fox, King Chan, Michael I Barbato, Thorkell Andressen, Naomi Taylor, Karel Pacak, J Keith Killian, Eva Dombi, W Marston Linehan, Markku M Miettinen, Richard L Piekarz, Lee J Helman, Paul S Meltzer, Brigitte C Widemann, John W Glod
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-associated Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Katie E Hebron, Xiaolin Wan, Jacob S Roth, David J Liewehr, Nancy E Sealover, William J E Frye, Angela Kim, Stacey Stauffer, Olivia L Perkins, Wenyue Sun, Kristine A Isanogle, Christina M Robinson, Amy James, Parirokh Awasthi, Priya Shankarappa, Xiaoling Luo, Haiyan Lei, Donna Butcher, Roberta Smith, Elijah F Edmondson, Jin-Qiu Chen, Noemi Kedei, Cody J Peer, Jack F Shern, William Douglas Figg, Lu Chen, Matthew D Hall, Simone Difilippantonio, Frederic G Barr, Robert L Kortum, Robert W Robey, Angelina V Vaseva, Javed Khan, Marielle E Yohe
The combination of trametinib and ganitumab is effective in RAS-mutated PAX-fusion negative rhabdomyosarcoma models. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Natalia Garcia, Vanessa Del Pozo, Marielle E Yohe, Craig M Goodwin, Terry J Shackleford, Long Wang, Kunal Baxi, Yidong Chen, Anna T Rogojina, Sara M Zimmerman, Cody J Peer, William Douglas Figg, Myron S Ignatius, Kris C Wood, Peter J Houghton, Angelina V Vaseva
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma. Molecular cancer therapeutics (2021)
Amélie Vézina, Monica Manglani, DreeAnna Morris, Brandon Foster, Matthew McCord, Hua Song, Meili Zhang, Dionne Davis, Wei Zhang, Jessica Bills, Kunio Nagashima, Priya Shankarappa, Jessica Kindrick, Stuart Walbridge, Cody J Peer, William Douglas Figg, Mark R Gilbert, Dorian B McGavern, Leslie L Muldoon, Sadhana Jackson
Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model. Molecular cancer research : MCR 19 (12) (2021)
Cody J Peer, Brian L Heiss, Daniel A Goldstein, Jennifer C Goodell, William D Figg, Mark J Ratain
A Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose De-Escalation. Journal of clinical pharmacology (2021)
Jing Wu, Ying Yuan, Debra A Long Priel, Danielle Fink, Cody J Peer, Tristan M Sissung, Yu-Ting Su, Ying Pang, Guangyang Yu, Madison K Butler, Tito R Mendoza, Elizabeth Vera, Salman Ahmad, Christine Bryla, Matthew Lindsley, Ewa Grajkowska, Kelly Mentges, Lisa Boris, Ramya Antony, Nancy Garren, Christine Siegel, Nicole Lollo, Christine Cordova, Orwa Aboud, Brett J Theeler, Eric M Burton, Marta Penas-Prado, Heather E Leeper, Javier Gonzales, Terri S Armstrong, Katherine R Calvo, William Douglas Figg, Douglas B Kuhns, John I Gallin, Mark R Gilbert
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Jin Wang, Bertrand Z Yeung, M Guillaume Wientjes, Minjian Cui, Cody J Peer, Ze Lu, William Douglas Figg, Sukyung Woo, Jessie L-S Au
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy. Pharmaceutics 13 (7) (2021)
Jay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, Jessica A Portillo, null null, Matthew D Zimmerman, Claire L Carter, Md Amir Hossen, Cody J Peer, Eric C Polley, Veronique Anne Dartois, William Douglas Figg, Niki M Moutsopoulos, Julie A Segre, Heidi H Kong
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics. Science translational medicine 13 (625) (2021)
Shaun D Fontaine, Gary W Ashley, Peter J Houghton, Raushan T Kurmasheva, Morgan Diolaiti, Alan Ashworth, Cody J Peer, Ryan Nguyen, William D Figg, Denis R Beckford-Vera, Daniel V Santi
A Very Long-Acting PARP Inhibitor Suppresses Cancer Cell Growth in DNA Repair-Deficient Tumor Models. Cancer research 81 (4) (2020)
Cody J Peer, Daniel A Goldstein, Jennifer C Goodell, Ryan Nguyen, William D Figg, Mark J Ratain
Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors. British journal of clinical pharmacology 86 (9) (2020)
Tristan M Sissung, Lisa M Cordes, Cody J Peer, Shruti Gandhy, Jason Mark Redman, Julius Strauss, William Douglas Figg
Case report: severe toxicity in an African-American patient receiving FOLFOX carrying uncommon allelic variants in DPYD. Pharmacogenomics 22 (2) (2020)
Christina Ross, Karol Szczepanek, Maxwell Lee, Howard Hua Yang, Cody J Peer, Jessica Kindrick, Priya Shankarappa, Zhi-Wei Lin, Jack D Sanford, William Douglas Figg, Kent W Hunter
Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures. Molecular cancer research : MCR 18 (9) (2020)
Chandra Kumar Elechalawar, Md Nazir Hossen, Priya Shankarappa, Cody J Peer, William Douglas Figg, J David Robertson, Resham Bhattacharya, Priyabrata Mukherjee
Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. International journal of nanomedicine 15 (2020)
Bih-Rong Wei, Shelley B Hoover, Cody J Peer, Jennifer E Dwyer, Hibret A Adissu, Priya Shankarappa, Howard Hua Yang, Maxwell Lee, Tyler J Peat, William Douglas Figg, R Mark Simpson
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma. Molecular cancer therapeutics 19 (11) (2020)
Cody J Peer, Oliver M Hall, Tristan M Sissung, Richard Piekarz, Sanjeeve Balasubramaniam, Susan E Bates, William D Figg
A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat. Cancer chemotherapy and pharmacology 82 (3) (2018)